BEAM
Beam Therapeutics Inc.
NASDAQHealthcareBiotechnologyUS
USD35.02
+0.07 (+0.20%)
Rating:C
Company Profile
CEO
John Evans
IPO Date
2020-02-06
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Market Metrics
Open
$34.83
Prev. Close
$34.95
Day Low
$33.73
Day High
$35.17
52W Low
$15.60
52W High
$36.88
Market Cap
$3.60B
Volume
0.46M